Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial
一项开放标签的1期临床试验评估了鼻内副流感病毒5型(PIV5)载体COVID-19疫苗在成人和青少年中的安全性和免疫原性
期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.adw0896
Spearman, Paul; Jin, Hong; Xiao, Peng; Knopp, Kristeene; Radziewicz, Henry; Tellier, Marinka; Larsen, Sasha E; Berube, Bryan J; Song, Xiao; Kidd, Jamie; Singh, Karnail; Li, Zhuo; Gingerich, Maria Cristina; Wu, Samuel; John, Susan P; Branche, Angela; Falsey, Ann R; Coler, Rhea; Villinger, Francois J; He, Biao